Literature DB >> 19465871

Age- and sex-related reference ranges of alanine aminotransferase levels in children: European paediatric HCV network.

Kirsty England1, Claire Thorne, Lucy Pembrey, Pier-Angelo Tovo, Marie-Louise Newell.   

Abstract

BACKGROUND: Serum alanine aminotransferase (ALT) levels are commonly used to indicate liver damage. Although elevated levels indicate possible liver injury, abnormalities, or disease, some patients with "normal" ALT levels have minimal to mild liver disease. Recently, ALT reference ranges for adults were queried and revised ranges proposed with lower upper limits of normality. The appropriateness of current paediatric ALT reference ranges is unclear.
MATERIAL AND METHODS: Hepatitis C virus (HCV)-uninfected children from the European Paediatric HCV Network represent a large population of healthy children born to HCV-infected mothers, with ALT observations collected prospectively from birth. Linear regression identified factors associated with ALT levels while accounting for within-child repeated measurements. ALT centiles stratified by sex were calculated using maximum penalized likelihood methods and LMS software.
RESULTS: A total of 1293 HCV-uninfected children had 5011 ALT measurements during follow-up. ALT levels significantly decreased with increasing age, whilst ALT levels were significantly lower in girls than boys. Reference cutoffs representing the 95th centiles before 18 months of age were 60 U/L for boys and 55 U/L for girls, decreasing to 40 U/L for boys and 35 U/L for girls after 18 months of age.
CONCLUSIONS: These reference ranges represent a unique investigation of ALT levels in a healthy child population. We show lower and more detailed age-related cutoffs of normality than available. Additionally, we demonstrate a significant effect of sex on ALT reference ranges, which has not previously been described in children younger than 5 years of age.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465871     DOI: 10.1097/MPG.0b013e31818fc63b

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  16 in total

1.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Authors:  Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong
Journal:  Hepatology       Date:  2018-04       Impact factor: 17.425

Review 2.  Development of biomarkers to optimize pediatric patient management: what makes children different?

Authors:  Jennifer Goldman; Mara L Becker; Bridgette Jones; Mark Clements; J Steven Leeder
Journal:  Biomark Med       Date:  2011-12       Impact factor: 2.851

3.  Repeated serum alkaline phosphatase measurements in the treatment of childhood acute bone and joint infections with high doses of antibiotics.

Authors:  Markus Pääkkönen; Markku J T Kallio; Pentti E Kallio; Heikki Peltola
Journal:  Ann Lab Med       Date:  2013-08-08       Impact factor: 3.464

Review 4.  Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease.

Authors:  Pierluigi Marzuillo; Anna Grandone; Laura Perrone; Emanuele Miraglia Del Giudice
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

5.  Adipocytokines as Risk Factors for Development of Nonalcoholic Fatty Liver Disease in Children.

Authors:  Paweł Małecki; Anna Mania; Joanna Tracz; Magdalena Łuczak; Katarzyna Mazur-Melewska; Magdalena Figlerowicz
Journal:  J Clin Exp Hepatol       Date:  2021-03-10

Review 6.  Persistent hypertransaminasemia in asymptomatic children: a stepwise approach.

Authors:  Pietro Vajro; Sergio Maddaluno; Claudio Veropalumbo
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

7.  Features of Severe Liver Disease With Portal Hypertension in Patients With Cystic Fibrosis.

Authors:  Jaclyn R Stonebraker; Chee Y Ooi; Rhonda G Pace; Harriet Corvol; Michael R Knowles; Peter R Durie; Simon C Ling
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-05       Impact factor: 11.382

8.  Children with Chronic Hepatitis B in the United States and Canada.

Authors:  Kathleen B Schwarz; Yona Keich Cloonan; Simon C Ling; Karen F Murray; Norberto Rodriguez-Baez; Sarah Jane Schwarzenberg; Jeffrey Teckman; Lilia Ganova-Raeva; Philip Rosenthal
Journal:  J Pediatr       Date:  2015-09-10       Impact factor: 4.406

9.  Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores.

Authors:  Thomas Karlas; Marie Neuschulz; Annett Oltmanns; Andrea Güttler; David Petroff; Hubert Wirtz; Jochen G Mainz; Joachim Mössner; Thomas Berg; Michael Tröltzsch; Volker Keim; Johannes Wiegand
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  First National Report on Aminotransaminases' Percentiles in Children of the Middle East and North Africa (MENA): the CASPIAN-III Study.

Authors:  Roya Kelishadi; Seyed-Hossein Abtahi; Mostafa Qorbani; Ramin Heshmat; Mohammad Esmaeil Motlagh; Mahnaz Taslimi; Tahereh Aminaee; Gelayol Ardalan; Parinaz Poursafa; Payam Moin
Journal:  Hepat Mon       Date:  2012-11-30       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.